In virtue of their TLR expression, B16 melanoma cells were found to respond to ligands to TLR3 and TLR4 by releasing substantial levels of IFN-I that induced DC activation and resulted in tumor growth inhibition by the host (84, 85). This evidence concerns the gene TLR4 and neoplasm.